269 related articles for article (PubMed ID: 28303942)
1. Signature of an aggregation-prone conformation of tau.
Eschmann NA; Georgieva ER; Ganguly P; Borbat PP; Rappaport MD; Akdogan Y; Freed JH; Shea JE; Han S
Sci Rep; 2017 Mar; 7():44739. PubMed ID: 28303942
[TBL] [Abstract][Full Text] [Related]
2. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
3. Conformation-based assay of tau protein aggregation.
Fichou Y; Eschmann NA; Keller TJ; Han S
Methods Cell Biol; 2017; 141():89-112. PubMed ID: 28882313
[TBL] [Abstract][Full Text] [Related]
4. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
5. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations.
Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G
Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046
[TBL] [Abstract][Full Text] [Related]
6. Initiation of assembly of tau(273-284) and its ΔK280 mutant: an experimental and computational study.
Larini L; Gessel MM; LaPointe NE; Do TD; Bowers MT; Feinstein SC; Shea JE
Phys Chem Chem Phys; 2013 Jun; 15(23):8916-28. PubMed ID: 23515417
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Role of ATP on PHF6 Aggregation.
Pal S; Roy R; Paul S
J Phys Chem B; 2022 Jul; 126(26):4761-4775. PubMed ID: 35759245
[TBL] [Abstract][Full Text] [Related]
8. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
[TBL] [Abstract][Full Text] [Related]
9. Regulation and aggregation of intrinsically disordered peptides.
Levine ZA; Larini L; LaPointe NE; Feinstein SC; Shea JE
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2758-63. PubMed ID: 25691742
[TBL] [Abstract][Full Text] [Related]
10. Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.
Ganguly P; Do TD; Larini L; LaPointe NE; Sercel AJ; Shade MF; Feinstein SC; Bowers MT; Shea JE
J Phys Chem B; 2015 Apr; 119(13):4582-93. PubMed ID: 25775228
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
12. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.
Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y
J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671
[TBL] [Abstract][Full Text] [Related]
13. Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau.
Pavlova A; Cheng CY; Kinnebrew M; Lew J; Dahlquist FW; Han S
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E127-36. PubMed ID: 26712030
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
15. The influence of the ΔK280 mutation and N- or C-terminal extensions on the structure, dynamics, and fibril morphology of the tau R2 repeat.
Raz Y; Adler J; Vogel A; Scheidt HA; Häupl T; Abel B; Huster D; Miller Y
Phys Chem Chem Phys; 2014 May; 16(17):7710-7. PubMed ID: 24448233
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the force fields on monomeric and fibrillar PHF6 of tau protein.
Li Y; Peng X
Biophys Chem; 2021 Oct; 277():106631. PubMed ID: 34116358
[TBL] [Abstract][Full Text] [Related]
17. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.
Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
KrishnaKumar VG; Paul A; Gazit E; Segal D
Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
[TBL] [Abstract][Full Text] [Related]
19. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
20. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
